These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17224858)

  • 1. Efficacy of citalopram on climacteric symptoms.
    Kalay AE; Demir B; Haberal A; Kalay M; Kandemir O
    Menopause; 2007; 14(2):223-9. PubMed ID: 17224858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot evaluation of citalopram for the relief of hot flashes.
    Barton DL; Loprinzi CL; Novotny P; Shanafelt T; Sloan J; Wahner-Roedler D; Rummans TA; Christensen B; Dakhill SR; Martin LS
    J Support Oncol; 2003; 1(1):47-51. PubMed ID: 15352642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.
    Freeman EW; Guthrie KA; Caan B; Sternfeld B; Cohen LS; Joffe H; Carpenter JS; Anderson GL; Larson JC; Ensrud KE; Reed SD; Newton KM; Sherman S; Sammel MD; LaCroix AZ
    JAMA; 2011 Jan; 305(3):267-74. PubMed ID: 21245182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
    Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
    Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.
    Suvanto-Luukkonen E; Koivunen R; Sundström H; Bloigu R; Karjalainen E; Häivä-Mällinen L; Tapanainen JS
    Menopause; 2005; 12(1):18-26. PubMed ID: 15668596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.
    Soares CN; Arsenio H; Joffe H; Bankier B; Cassano P; Petrillo LF; Cohen LS
    Menopause; 2006; 13(5):780-6. PubMed ID: 16894334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a combination of Nigella sativa and Vitex agnus-castus with citalopram on healthy menopausal women with hot flashes: results from a subpopulation analysis.
    Molaie M; Darvishi B; Jafari Azar Z; Shirazi M; Amin G; Afshar S
    Gynecol Endocrinol; 2019 Jan; 35(1):58-61. PubMed ID: 30129806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial.
    Ensrud KE; Joffe H; Guthrie KA; Larson JC; Reed SD; Newton KM; Sternfeld B; Lacroix AZ; Landis CA; Woods NF; Freeman EW
    Menopause; 2012 Aug; 19(8):848-55. PubMed ID: 22433978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
    Albertazzi P
    J Br Menopause Soc; 2006 Mar; 12(1):7-11. PubMed ID: 16513016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial.
    LaCroix AZ; Freeman EW; Larson J; Carpenter JS; Joffe H; Reed SD; Newton KM; Seguin RA; Sternfeld B; Cohen L; Ensrud KE
    Maturitas; 2012 Dec; 73(4):361-8. PubMed ID: 23031421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of abrupt discontinuation versus gradual dose reduction of postmenopausal hormone therapy on hot flushes.
    Cunha EP; Azevedo LH; Pompei LM; Strufaldi R; Steiner ML; Ferreira JA; Peixoto S; Fernandes CE
    Climacteric; 2010 Aug; 13(4):362-7. PubMed ID: 20151792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses.
    Carranza-Lira S; Gooch AL; Saldivar N; Osterwalder MS
    Int J Fertil Womens Med; 2007; 52(2-3):93-6. PubMed ID: 18320867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot study.
    Defronzo Dobkin R; Menza M; Allen LA; Marin H; Bienfait KL; Tiu J; Howarth J
    Ann Clin Psychiatry; 2009; 21(2):70-6. PubMed ID: 19439155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies.
    Nagata H; Nozaki M; Nakano H
    J Obstet Gynaecol Res; 2005 Apr; 31(2):107-14. PubMed ID: 15771635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.
    Barton DL; LaVasseur BI; Sloan JA; Stawis AN; Flynn KA; Dyar M; Johnson DB; Atherton PJ; Diekmann B; Loprinzi CL
    J Clin Oncol; 2010 Jul; 28(20):3278-83. PubMed ID: 20498389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone.
    von Holst T; Lang E; Winkler U; Keil D
    Maturitas; 2002 Dec; 43(4):265-75. PubMed ID: 12468135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
    Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
    JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.
    Caan B; LaCroix AZ; Joffe H; Guthrie KA; Larson JC; Carpenter JS; Cohen LS; Freeman EW; Manson JE; Newton K; Reed S; Rexrode K; Shifren J; Sternfeld B; Ensrud K
    Menopause; 2015 Jun; 22(6):607-15. PubMed ID: 25405571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
    Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effectiveness of Melissa Officinalis L. versus Citalopram on Quality of Life of Menopausal Women with Sleep Disorder: A Randomized Double-Blind Clinical Trial.
    Shirazi M; Jalalian MN; Abed M; Ghaemi M
    Rev Bras Ginecol Obstet; 2021 Feb; 43(2):126-130. PubMed ID: 33465795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.